Assessment of cerebral perfusion alterations in dementia with Lewy bodies and Alzheimer’s disease Authors: Yanlai Xia, Huanjing Jiao, Junling Han, Ying Guo, Xiaoxi Niu, Yong Ji, Hongyan Ni Published: 2024 ABSTRACT AbstractBackgroundDementia with Lewy bodies (DLB) and Alzheimer’s disease (AD) are common forms of dementia, characterized by overlapping clinical symptoms. Functional neuroimaging can provide valuable information for precise diagnosis. Our objective was to explore cerebral perfusion alterations in DLB and AD, and to determine which perfusion parameters are helpful in distinguishing DLB and AD.MethodsA total of 25 DLB patients, 34 AD patients, and 40 normal controls (NC) underwent neuropsychological testing and pseudo-continuous arterial spin labeling (pcASL) for assessing cerebral perfusion [mean cerebral flow (mCBF); arterial transit time (ATT)] indexes. Differences in perfusion indexes among the three groups were analyzed and the family-wise error (FWE) was used for multiple comparisons. Spearman analysis assessed the relationships between the mCBF and neuropsychological scores [mini-mental state examination (MMSE); Montreal Cognitive Assessment (MoCA)]. A receiver operating characteristic (ROC) analysis was conducted to evaluate the performance and discriminant value of different perfusion indices in distinguishing between the two diseases.ResultsCompared with NC, the mCBF of patients with DLB was reduced mainly in the bilateral frontal lobe, bilateral parietal lobes, bilateral temporal lobes, and the right occipital lobe. AD patients showed lower mCBF mainly in the bilateral frontal lobes, the right temporal lobe, and the left parietal lobe. Compared with AD, DLB patients showed decreased mCBF in the bilateral frontal and parietal lobes. ATT in almost all major arterial regions was prolonged in DLB and AD when compared to NC. Compared with AD, ATT was significantly prolonged in DLB (P<0.05). Furthermore, the DLB demonstrated a significant positive correlation between mCBF and MMSE scores, particularly in regions such as the left superior parietal lobule (r=0.596, P=0.002) and the right precuneus (r=0.498, P=0.01). Similarly, AD exhibits a positive correlation between mCBF and MMSE scores within regions, such as the right middle temporal gyrus (r=0.550, P=0.001) and the left inferior parietal lobule (r=0.571, P<0.001). The perfusion indexes could help distinguish DLB from AD.ConclusionsDLB demonstrates a different pattern of regional blood flow reduction and prolonged ATT, which is different from that in AD. ASL-derived parameters provide critical discriminative information for differentiating DLB and AD.Keywords: Dementia with Lewy bodies (DLB), Alzheimer’s disease (AD), cerebral blood flow (CBF), arterial transit time (ATT), arterial spin labeling (ASL) Introduction Dementia with Lewy bodies (DLB) is the second most prevalent form of dementia after Alzheimer’s disease (AD). The main clinical features of DLB are fluctuating cognitive dysfunction, visual hallucinations, and resting tremor (1). AD is a progressive disease in the elderly, with a slow onset, mainly characterized by loss of memory, cognitive function, and daily social interaction. Conversely, DLB at the early stage may have no significant cognitive changes (2). Moreover, patients with advanced DLB may present with AD symptoms such as weakness in visual memory, short-term memory, and so on, making the diagnosis of DLB difficult to establish (1,3-5). AD neuropathological changes are common in individuals with a clinical diagnosis of DLB, and a large study has shown that the majority of DLB patients (>70%) have AD neuropathological changes (6). The clinical manifestations and pathological underpinnings of DLB are multifaceted, exhibiting similarities with those of AD. Consequently, the diagnosis and differential diagnosis of these conditions pose significant challenges. Recent studies have shown that blood-brain barrier (BBB) dysfunction also plays an important role in the onset and progression of dementia (7-11). These processes are intricately associated with brain activity and energy consumption. One important technique for the evaluation of neural activity in brain tissue is arterial spin labeling (ASL), a non-invasive, ubiquitously available, and radiation-free magnetic resonance imaging (MRI) technique (12,13). ASL measures cerebral blood flow (CBF) by using magnetically-labeled arterial blood flow as the endogenous contrast agent and the pseudo-continuous ASL (pcASL) allows for the acquisition of high signal-to-noise images by using a large string of short pulses of approximately 1 ms in length to form a pulse sequence of 1–2 seconds in length (14). The pcASL technique uses multiple post-labeling delay (PLD) times to calculate arterial transit time (ATT), offers superior quantification of blood perfusion, and improves the precision of mean CBF (mCBF) measurements (15). Previous studies have shown that ASL-MRI could demonstrate comparable regional perfusion patterns to those employing single photon emission computed tomography (SPECT) in AD (16-18). Similarly, ASL studies have yielded comparable results in DLB (19,20). Reductions in CBF have been found in both DLB and AD. Several studies have reported that in AD, CBF changes mainly occur in the temporal parietal regions (21) and posterior cingulate gyrus (22,23). Compared with AD, studies have shown hypoperfusion in the temporal parietal (24), frontal lobe, posterior cingulate, medial, and lateral occipital lobes (25) in DLB (26,27). Furthermore, DLB exhibits a lack of occipital perfusion (28,29) and relative preservation of perfusion in the medial temporal lobe (30); CBF has been observed to be decreased throughout the brain (31). One study revealed CBF reduction in the frontal, insular, and temporal cortices in DLB, whereas decreased perfusion in the parietal and temporal cortices was observed in AD (27). With the increase of age or the presence of vascular pathology, the ATT is prolongated, which reflects the extended time between the labeling of blood and its arrival in brain tissue. Few previous studies have reported ATT changes in DLB and AD. In an early study, Yoshiura et al. (32) suggested regions of localized zones of hypoperfusion in AD independent of prolongation of the regional ATT, speculating that the mechanism of hypoperfusion in AD differs from cerebrovascular disease. One study (33) reported that regional ATT of AD in the left inferior frontal gyrus and cingulate gyrus was prolonged, and ATT was correlated with mini-mental state examination (MMSE) scores. Furthermore, ATT prolongation might be a neuroimaging marker to detect the presence of neuropsychiatric symptoms in dementia (34). However, the difference between ATT in DLB and AD has not been fully investigated. To date, the literature on ATT extension is limited and remains conflicting. Therefore, this study mainly focuses on the CBF changes in DLB and AD, seeks to investigate the pattern of cerebral perfusion alterations, and explores the correlation between pcASL-derived indices and cognitive scales. The primary goal is to detect whether perfusion indexes could be a new imaging marker that effectively differentiates between the two diseases. We present this article in accordance with the STROBE reporting checklist (available at https://qims.amegroups.com/article/view/10.21037/qims-24-946/rc). Methods Participants The study was conducted in accordance with the Declaration of Helsinki (as revised in 2013). The study was approved by the Medical Ethics Committee of Tianjin First Central Hospital (No. 2018N141KY) and informed consent was provided by all individual participants. A total of 99 participants enrolled in this study, including 25 patients with DLB, 34 patients with AD, and 40 healthy elderly individuals, all of whom were recruited in Tianjin First Central Hospital between 1 September 2022 and 31 January 2024. All patients were screened for dementia, including history, physical, neuropsychological testing, and brain MRI. Neuropsychological scales used included the MMSE and Montreal Cognitive Assessment (MoCA). AD patients met the criteria for probable AD proposed by the National Institute on Aging and Alzheimer’s Disease Association (NIA-AA) (35,36); DLB diagnosis was established following the clinical criteria proposed by the DLB Consortium’s Fourth Consensus Report for probable DLB (1). The exclusion criteria were as follows: (I) left-handedness; (II) presence of severe cerebrovascular disease; (III) patients with mental disorders or a history of severe head trauma; (IV) recent diagnosis with a serious systemic disease; and (V) poor post-processed image quality. MRI acquisition MRI data were acquired using a 3-T MAGNETOM Prisma MR scanner (Siemens Healthcare, Erlangen, Germany) with a 64-channel head-neck coil. Structural images including high-resolution T1-weighted using three-dimensional (3D) magnetization-prepared rapid acquisition gradient echo sequences (3DT1WI-MPRAGE) were acquired with parameters echo time (TE) =2.98 ms, repetition time (TR) =1,550 ms, flip angle (FA) =9°, voxel size =1.0×1.0×1.0 mm3, field of view (FOV) =256×256 mm2, and a T2 fluid-attenuated inversion recovery (dark-fluid) sequence [TR =8,000 ms, TE =85 ms, inversion time (TI) =2,373 ms, FA =150°]. pcASL images were acquired using the following parameters: multiple PLD time =500, 1,000, 1,500, 2,000, and 2,500 ms; TE =36.48 ms; TR =4,100 ms; FA =120°, FOV =240×240 mm2; slice thickness =3.0 mm; voxel size: 2.5×2.5×3.0 mm; and acquisition time =7 min 11 s. Data processing The ASL data were processed utilizing the cereflow software (http://www.cereflow.cn) (37), where motion correction was systematically applied to all ASL image sequences. Subtraction of the label images from the control images was performed in pairs, followed by averaging to generate the mean difference image. M0 images were registered to the structural image. Subsequently, the resultant cerebral perfusion parameter maps including mCBF and ATT (38) were also aligned with the structural images. The origin and head motion corrections were performed before T1-weighted imaging (T1WI) image preprocessing. Then, the anatomical images were segmented into gray matter (GM), white matter (WM), and cerebrospinal fluid (CSF) tissue. Perfusion images were co-registered with those images. Partial volume correction [partial volume effects (PVE) correction, PVEc] was implemented by tissue probability maps in statistical parametric mapping (SPM) toolbox PETPVE12 (39). We used the Müller-Gärtner (40) approach. Ultimately, the arterial supply region brain atlas (41) and Alberta Stroke Program Early CT Score (ASPECTS) (42) were overlaid. The mCBF and ATT values for each region of interest (ROI) were automatically extracted from automated anatomical labeling (AAL) atlas in precision. Statistical analyses The statistical software SPSS 26.0 (IBM Corp., Armonk, NY, USA) was performed for the demographic data and cognitive scores of all cases. A P value <0.05 was considered statistically significant. The Kolmogorov-Smirnov was used to test whether the statistics follow a normal distribution. Categorical variables were expressed as counts. Variables that conform to a normal distribution were represented as mean ± standard deviation (SD). Non-normal distribution data were represented as median (interquartile range). A Chi-squared test was used for sex distribution. For continuous measures, differences among the groups were tested with analysis of variance (ANOVA) and Bonferroni tests for multiple comparisons. Differences in mCBF between groups were analyzed in SPM 12 (https://www.fil.ion.ucl.ac.uk/spm/software/spm12/) package running on Matlab 2022a (MathWorks, Natick, MA, USA), with age, sex, and education years as covariates and general linear model (GLM) was created to identify regional changes. A family-wise error (FWE) correction P<0.05 was considered statistically significant. After that, we used xjview10.0 (https://www.alivelearn.net/xjview/xjview-10-0-released/) toolbox to record cluster voxels by the atlas of AAL3. The perfusion values in the ROIs of the AAL3 atlas were extracted in Matlab 2022a using the DPABIV 7.0 (https://rfmri.org/DPABI). Moreover, we used ANOVA to assess the ATT differences, with age, gender, and educational year as covariates in the deep perforating branches of the bilateral anterior arteries, the meningeal branches of the bilateral anterior arteries, the bilateral anterior choroidal arteries, the anterior perforating branches of the bilateral middle arteries, the meningeal branches of the bilateral middle arteries, the meningeal branches of the bilateral posterior arteries, and the meningeal branches of the bilateral posterior arteries. Post-hoc comparisons were made using the Bonferroni test. Spearman correlation analysis was performed on the mCBF indexes and neuropsychological scores, and the correlation coefficient was calculated. Receiver operating characteristic (ROC) curve analysis was used to assess the classified performance of cerebral perfusion indexes. Results Demographics and clinical scores Totals of 25 DLB patients, 34 AD patients, and 40 healthy controls were included in the study; the demographic data for all cases are summarized in Table 1. There were no observed significant differences in age, sex, and years of education among the three groups (P>0.05). The MMSE, MoCA, and Clinical Dementia Rating (CDR) scores were significantly different between the groups (P<0.05). Bonferroni comparison analyses further showed that there was no significant difference between DLB and AD in terms of MMSE and MoCA scores (P>0.05). Table 1Demographics and clinical scores of participantsVariablesDLB (n=25)AD (n=34)NC (n=40)P valueSex (male/female)15/1010/2417/230.06†Age (years)71.76±6.3470.74±9.2467.68±7.350.09‡Education (years)10.68±4.8510.41±3.4112.38±3.220.058‡MMSE scores18.0 (12.00, 22.50)115.50 (10.00, 20.00)229.00 (28.00, 30.00)<0.001§**MoCA scores14.00 (7.50, 18.00)110.00 (7.75, 16.00)227.00 (25.25, 28.00)<0.001§**CDR scores1.56±0.1811.10±0.1020.00<0.001‡,**A Chi-squared test was performed for sex comparisons. Age, education, CDR scores are presented as mean ± SD. MMSE, and MoCA scores are presented as median (interquartile range). †, P values are from the Chi-squared test; ‡, P values are from the ANOVA test; §, P values are from Kruskal-Wallis H test. Post-hoc comparison was significant (P<0.05): 1, DLB vs. NC; 2, AD vs. NC. **, P<0.001 was considered a significant difference. DLB, dementia with Lewy bodies; AD, Alzheimer’s disease; NC, normal controls; MMSE, mini-mental state examination; MoCA, Montreal Cognitive Assessment; CDR, Clinical Dementia Rating; ANOVA, analysis of variance; SD, standard deviation. Demographics and clinical scores of participants A Chi-squared test was performed for sex comparisons. Age, education, CDR scores are presented as mean ± SD. MMSE, and MoCA scores are presented as median (interquartile range). †, P values are from the Chi-squared test; ‡, P values are from the ANOVA test; §, P values are from Kruskal-Wallis H test. Post-hoc comparison was significant (P<0.05): 1, DLB vs. NC; 2, AD vs. NC. **, P<0.001 was considered a significant difference. DLB, dementia with Lewy bodies; AD, Alzheimer’s disease; NC, normal controls; MMSE, mini-mental state examination; MoCA, Montreal Cognitive Assessment; CDR, Clinical Dementia Rating; ANOVA, analysis of variance; SD, standard deviation. The contrast of mCBF changes among the three groups The location of differences in mCBF among the three groups is shown in Figures 1-3, and Table 2 lists detailed information about these parts of the brain. As shown in Figure 1, compared with NC, there was a notable decrease in mCBF in DLB, with the most pronounced reductions occurring in the bilateral frontal lobes, bilateral parietal lobes, bilateral temporal lobes, and the right occipital lobe. In comparison to NC, AD exhibited a notable reduction perfusion, predominantly affecting the bilateral frontal lobes, the right temporal lobe, and the left parietal lobe (Figure 2). Contrasted with AD, DLB exhibited a decreased mCBF primarily in the bilateral frontal and parietal lobes (Figure 3). No statistically significant brain regions were detected where CBF in DLB was higher than it was in AD. Cluster showing mCBF changes (NC > DLB). Significant mCBF changes in DLB compared with NC. The color bar represents T values. Clusters survived correction with the FWE correction settled at P<0.05. mCBF, mean cerebral blood flow; DLB, dementia with Lewy bodies; NC, normal controls; FWE, family-wise error. Cluster showing mCBF changes (NC > AD). Significant mCBF changes in AD compared with NC. The color bar represents T values. Clusters survived correction with the FWE correction settled at P<0.05. mCBF, mean cerebral blood flow; AD, Alzheimer’s disease; NC, normal controls; FWE, family-wise error. Cluster showing mCBF changes (AD > DLB). Significant mCBF changes in AD compared with DLB. The color bar represents T values. Clusters survived correction with the FWE correction settled at P<0.05. mCBF, mean cerebral blood flow; AD, Alzheimer’s disease; DLB, dementia with Lewy bodies; FWE, family-wise error. Table 2Cluster region of the comparisonPeak regionHemisphereCluster (voxels)Peak-MNI coordinatesPeak t-statisticxyzNC > DLB FusiformR82325−58−116.0693 Anterior cingulate cortex, subgenualR944530−75.7246 PrecuneusL2,311−5−55535.2229 LingualL644−23−44−65.8298NC > AD Temporal pole: superior temporal gyrusR6,5115212−95.7251 Inferior parietal gyrusL3,334−55−24495.3134AD > DLB Parietal lobeR1,73329−30506.5214 PostcentralL1,298−39−29565.3076 Superior parietal gyrusR70125−60545.0668Cluster index and size for Figures 1-3. Cluster index was extracted using the xjview tools and are corrected for multiple comparisons. AD, Alzheimer’s disease; DLB, dementia with Lewy bodies; NC, normal controls; MNI, Montreal Neurological Institute; R, right; L, left. Cluster region of the comparison Cluster index and size for Figures 1-3. Cluster index was extracted using the xjview tools and are corrected for multiple comparisons. AD, Alzheimer’s disease; DLB, dementia with Lewy bodies; NC, normal controls; MNI, Montreal Neurological Institute; R, right; L, left. The contrast of ATT changes among the three groups The differences in ATT values among the three groups in bilateral anterior deep perforator arteries (ACAPerf), bilateral anterior choroidal arteries (AchA), bilateral anterior meningeal arteries (ACAm), bilateral middle meningeal arteries (MCAm), bilateral middle deep perforator arteries (MCAPerf), and bilateral posterior meningeal arteries (PCAm) were statistically significant (P<0.05, Bonferroni comparison was used for multiple comparison, Table 3). The ATT values of the above region in DLB were significantly longer than NC. The left ACAPerf’s ATT of AD was longer than that of NC, but the other regions did not reach the level of statistical significance. Moreover, the ATT of DLB in almost all of the above-mentioned arteries were longer than AD (except the left ACAPerf). Table 3Comparison of ATT in each brain region between the three groupsHemisphereArteryDLB (s)AD (s)NC (s) F P valueLAnterior deep perforator1.19±0.18‡1.10±0.18§1.00±0.188.1530.001*RAnterior deep perforator1.18±0.23†‡1.02±0.221.01±0.175.9240.004*LAnterior choroidal1.07±0.23†‡0.90±0.180.89±0.139.054<0.001**RAnterior choroidal1.09±0.25†‡0.90±0.160.85±0.1414.201<0.001**LAnterior meningeal1.25±0.12†‡1.10±0.141.08±0.1413.425<0.001**RAnterior meningeal1.25±0.13†‡1.09±0.151.08±0.1512.407<0.001**LMiddle meningeal1.26±0.12†‡1.10±0.151.10±0.1214.17<0.001**RMiddle meningeal1.27±0.15†‡1.11±0.151.09±0.1314.595<0.001**LMiddle deep perforator1.14±0.20†‡0.96±0.200.90±0.1613.744<0.001**RMiddle deep perforator1.17±0.20†‡0.98±0.210.90±0.1616.424<0.001**LPosterior meningeal1.32±0.15†‡1.21±0.131.20±0.146.557<0.001**RPosterior meningeal1.30±0.16†‡1.19±0.111.18±0.137.891<0.001*Data are presented as mean ± SD. *, P<0.05; **, P<0.001 (†, DLB vs. AD; ‡, DLB vs. NC; §, AD vs. NC). ATT, arterial transit time; DLB, dementia with Lewy bodies; AD, Alzheimer’s disease; NC, normal controls; s, second; R, right; L, left; SD, standard deviation. Comparison of ATT in each brain region between the three groups Data are presented as mean ± SD. *, P<0.05; **, P<0.001 (†, DLB vs. AD; ‡, DLB vs. NC; §, AD vs. NC). ATT, arterial transit time; DLB, dementia with Lewy bodies; AD, Alzheimer’s disease; NC, normal controls; s, second; R, right; L, left; SD, standard deviation. Relationship between cerebral perfusion indexes and neuropsychological scales The relationship between cerebral perfusion indexes and neuropsychological scales is shown in Figure 4. In DLB, MMSE scores were significantly positively correlated with the left superior parietal gyrus’s mCBF (r=0.596, P=0.002) (Figure 4A). Similarly, the DLB’s mCBF in the right precuneus was positively correlated with MMSE scores (r=0.498, P=0.01) (Figure 4B). Likewise, the AD showed that mCBF in the right middle temporal gyrus was significantly positively correlated with MoCA scores (r=0.550, P=0.001) (Figure 4C), and the AD’s mCBF in the left inferior parietal gyrus was significantly positively correlated with MoCA scores (r=0.571, P<0.001) (Figure 4D). Relationship between perfusion index and neuropsychological scores. (A,B) DLB’s correlation between mCBF and neuropsychological scores; (C,D) AD’s correlation between mCBF and neuropsychological scores. R, right; L, left; MMSE, mini-mental state examination; MoCA, Montreal Cognitive Assessment; DLB, dementia with Lewy bodies; mCBF, mean cerebral blood flow; AD, Alzheimer’s disease. Assessment for diagnosis value of cerebral perfusion indices As shown in Figure 5, ROC curve analysis showed that the area under the curve (AUC) was 0.709 for the precuneus (mCBF), and 0.861 for the anterior perforating branches of the middle arteries (ATT) in diagnosing DLB and NC. Between DLB and AD, the AUC values of mCBF for precuneus and anterior perforating branches of the middle arteries ATT were 0.759 and 0.724, respectively. The AUC values for mCBF and ATT were 0.639 (parahippocampal) and 0.634 (right middle deep perforator artery), respectively, between AD and NC. ROC curve of the perfusion index for discriminating. The ROC curves of the mCBF: (A) DLB vs. NC; (B) DLB vs. AD; (C) AD vs. NC, and the ROC curves of the ATT: (D) DLB vs. NC; (E) DLB vs. AD; (F) AD vs. NC. Sensitivity = true-positive fraction. DLB, dementia with Lewy bodies; NC, normal controls; mCBF, mean cerebral blood flow; AUC, area under the curve; AD, Alzheimer’s disease; ATT, arterial transit time; ROC, receiver operator characteristic. Discussion In our study, we explored CBF and characteristics of perfusion changes in DLB and AD, and evaluated whether pcASL-derived perfusion indices would help for diagnosis. There were three main outcomes: (I) both DLB and AD have notable reductions in CBF, and prolonged ATT. Hypoperfusion in DLB was observed more extensively; (II) reduced CBF was strongly associated with cognitive performance; (III) CBF and ATT can provide a new view for distinguishing DLB from AD. The leakage of the BBB and the clearance of CSF play crucial roles in DLB and AD (8-11,43). These processes are closely associated with brain activity and energy demand, which could be detected by ASL and other functional techniques. Our findings indicate that DLB and AD exhibit distinct patterns of CBF alterations. DLB had reduced blood flow in several regions, particularly bilateral frontal lobes, bilateral parietal lobes, bilateral temporal lobes, and the right occipital lobe in contrast to NC. One of the core symptoms of DLB is the presence of visual hallucinations. Previous studies have speculated on a potential relationship between visual hallucinations and the visual cortex (44), but failed to demonstrate any correlation between decreased occipital perfusion and visual hallucinations (25). One study found that DLB with or without hallucinations has no significant difference in occipital blood flow (45). An ASL-based study (27) also did not show occipital hypoperfusion in mild DLB. Is noteworthy that the scores of mild DLB were similar to those of the DLB patients in our study. Whether visual hallucinations in DLB are related to occipital hypoperfusion and can be tracked using the dynamic tracking of the characteristic brain regions with altered blood flow by ASL remains questionable, requiring a large number of cases and great effort to ascertain. We also found that the mCBF in the parietal lobe and temporal lobe of the DLB cases were significantly lower in comparison to NC, which was also found in a previous study (45). As the disease progressed, there was a spread in cerebral hypoperfusion to the frontal cortex and temporal lobe, which was also seen in our study (46). Moreover, studies have also reported that DLB patients have reduced blood flow in the supraorbital gyrus, parietal gyrus, middle temporal gyrus, and insular and inferior frontal gyrus compared to controls (27,47). Equivalently, AD patients had lower mCBF primarily in the bilateral frontal lobes, the right temporal lobe, and the left parietal lobe, which is similar to the findings of previous studies (48,49). Furthermore, it has been shown that the left middle temporal gyrus is an important hub for AD to connect GM atrophy, cerebral perfusion deficits, and cognitive deficits (21). We have also confirmed the presence of DLB had a more diffuse pattern of functional changes than AD, including perfusion changes in the frontal lobe and temporal regions (27,50). In our present study, DLB showed more extensive mCBF changes, with areas of hypoperfusion concentrated in the postcentral gyrus, parietal lobe, and precuneus in contrast to AD (30,51-56). Our results indicated the presence of prolonged ATT in DLB and AD. PLD defines the interval between blood labeling and image acquisition, and ATT refers to the time required for arterial blood to reach the acquisition level from the labeling level (12,57). Aging may affect the lengthening of ATT and subsequently the CBF (58). The anterior cerebral artery (ACA), the main artery supplying the medial part of the cerebral hemispheres, reduces blood flow to the brain regions supplied by the deep perforating branches of the anterior arteries and anterior choroidal arteries (41), including the medial frontal, medial parietal, and anterior basal ganglia, which may lead to loss of the olfaction, hemiparesis of the muscles of the lower limbs, loss of sensation in the legs and perineum, and incontinence (59-61). DLB patients were more likely to exhibit those symptoms, which may be associated with more severe damage to blood vessels. Moreover, a reduction in CBF to the middle cerebral artery (MCA) results in impaired function of the brain areas supplied by the deep and meningeal branches of the MCA, including the frontal lobe, temporal lobe, parietal lobe, corona radiata, pallidum, and caudate nucleus, which may lead to facial paralysis (62), sensory impairment of the limbs or hemiparesis, speech impairment, and visual impairment (63-65). This could be an explanation for patients with DLB and moderate AD having symptoms of facial stiffness and slow movements. Reduced blood supply of the posterior meningeal arteries can lead to reduced blood flow to the occipital lobe, medial temporal lobe, most of the thalamus, and other regions, which may cause vision loss (66). ATT may be prolonged due to hypoperfusion caused by degeneration of local nerve tissue or the “remote effect” of nerve degeneration in distant brain regions for AD. The study of ATT in AD is controversial and not fully understudied. Yoshiura et al. (32) suggested that region ATT in the hypoperfusion area of AD was not significantly prolonged. However, Mak et al. (33) showed that AD involves a significant hemodynamic disorder, whereby ATT in the left inferior frontal gyrus and middle cingulate gyrus were prolonged. Sun et al. (67) found that the multi-delay combination of CBF and ATT could gain high performance in the identification of AD. Furthermore, the prolongation of ATT in the main artery was significant in DLB, which may be evidence of greater hemodynamic disorder in DLB. Additionally, we found that some regions of mCBF are positively correlated with neuropsychological scores. We found that the left cingulate cortex, left angular, and supramarginal gyri in DLB have a weak correlation with scores (68). Furthermore, research has shown that reduced CBF is associated with a faster rate of cognitive decline (69). One study (33) found significant hemodynamic deficits in AD, with regional CBF positively correlated with MMSE scores. We suggest that perfusion indices could offer a new point to distinguish between different conditions (67). It is worth noting that DLB and AD exhibited distinct characteristics of CBF and ATT changes. Our findings suggest that ATT sometimes may be a more accurate indicator than CBF for the differential diagnosis between DLB and AD. It may be associated with reduced blood flow in the medial frontal lobe and basal ganglia of AD, as well as decreased memory and cognition. This undoubtedly facilitates a more comprehensive comprehension of the underlying mechanisms that contribute to cognitive impairment. Previous studies have predominantly employed rotational labeling of arteries with a single PLD or two PLDs, yet these methodologies are susceptible to erroneous CBF measurements. In this study, pcASL was employed to reduce the total acquisition time and to permit the simultaneous acquisition of ATT and mCBF (70). This sequence also facilitated the selection of appropriate PLDs based on known ATT, thereby ensuring more accurate mCBF measurements (67). Limitations Nevertheless, there are several limitations to this study: (I) the sample sizes were small and the distribution of each group was not equitable, which may have caused some bias; (II) the incomplete biomarkers may conceal co-AD-pathology in DLB patients. This study failed to incorporate the various stages of progressive diseases. Moreover, our approach was limited to cross-sectional diagnoses across the patient population, necessitating future longitudinal studies for a more comprehensive understanding. Prolonged clinical follow-up could significantly refine the precision of ASL techniques in identifying CBF modifications linked to neurodegenerative disorders, thereby improving diagnostic accuracy. Conclusions DLB and AD display distinct cerebral perfusion changes, and DLB has more extensive brain perfusion alterations. Cerebral perfusion indices can help distinguish DLB from AD. The measurements of CBF and ATT indices by pcASL could advance our understanding of the potential perfusion alteration of DLB and AD patients. Supplementary The article’s supplementary files as Acknowledgments Funding: This work was supported by the Natural Scientific Foundation of China (grant No. 30870713), the Tianjin Natural Science Foundation Project (grant No. 21JCZDJC01210), and the Tianjin Health Science and Technology Project (grant No. ZC20161). Ethical Statement: The authors are accountable for all aspects of the work in ensuring that questions related to the accuracy or integrity of any part of the work are appropriately investigated and resolved. The study was conducted in accordance with the Declaration of Helsinki (as revised in 2013). The study was approved by the Medical Ethics Committee of Tianjin First Central Hospital (No. 2018N141KY) and informed consent was provided by all individual participants. Footnotes Reporting Checklist: The authors have completed the STROBE reporting checklist. Available at https://qims.amegroups.com/article/view/10.21037/qims-24-946/rc Conflicts of Interest: All authors have completed the ICMJE uniform disclosure form (available at https://qims.amegroups.com/article/view/10.21037/qims-24-946/coif). The authors have no conflicts of interest to declare. References Associated Data Supplementary Materials The article’s supplementary files as